Abstract
The serine/threonine kinase human Pim1 (hereafter PIM1) cooperates with human c-Myc (hereafter MYC) in cell cycle progression and tumorigenesis. However, the nature of this cooperation is still unknown. Here we show that, after stimulation with growth factor, PIM1 forms a complex with the dimer of MYC with MAX (Myc-associated factor X) via the MYC BoxII (MBII) domain. MYC recruits PIM1 to the E boxes of the MYC-target genes FOSL1 (FRA-1) and ID2, and PIM1 phosphorylates serine 10 of histone H3 (H3S10) on the nucleosome at the MYC-binding sites, contributing to their transcriptional activation. MYC and PIM1 colocalize at sites of active transcription, and expression profile analysis revealed that PIM1 contributes to the regulation of 20% of the MYC-regulated genes. Moreover, PIM1-dependent H3S10 phosphorylation contributes to MYC transforming capacity. These results establish a new function for PIM1 as a MYC cofactor that phosphorylates the chromatin at MYC-target loci and suggest that nucleosome phosphorylation, at E boxes, contributes to MYC-dependent transcriptional activation and cellular transformation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Strahl, B. D. & Allis, C. D. The language of covalent histone modifications. Nature 403, 41–45 (2000).
Berger, S. L. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev. 12, 142–148 (2002).
Cheung, P., Allis, C. D. & Sassone-Corsi, P. Signaling to chromatin through histone modifications. Cell 103, 263–271 (2000).
Nowak, S. J. & Corces, V. G. Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet. 20, 214–220 (2004).
Thomson, S., Mahadevan, L. C. & Clayton, A. L. MAP kinase-mediated signalling to nucleosomes and immediate-early gene induction. Semin. Cell Dev. Biol. 10, 205–214 (1999).
Sassone-Corsi, P. et al. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 285, 886–891 (1999).
Soloaga, A. et al. MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO J. 22, 2788–2797 (2003).
Yamamoto, Y., Verma, U. N., Prajapati, S., Kwak, Y. T. & Gaynor, R. B. Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression. Nature 423, 655–659 (2003).
Anest, V. et al. A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression. Nature 423, 659–663 (2003).
Cuypers, H. T. et al. Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell 37, 141–150 (1984).
Zippo, A., De Robertis, A., Bardelli, M., Galvagni, F. & Oliviero, S. Identification of Flk-1-target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood 103, 4536–4544 (2004).
van Lohuizen, M. et al. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell 56, 673–682 (1989).
van Lohuizen, M. et al. Identification of cooperating oncogenes in E μ-myc transgenic mice by provirus tagging. Cell 65, 737–752 (1991).
Verbeek, S. et al. Mice bearing the E μ-myc and E μ-pim-1 transgenes develop pre-B-cell leukemia prenatally. Mol. Cell. Biol. 11, 1176–1179 (1991).
Wang, Z. et al. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J. Vet. Sci. 2, 167–179 (2001).
Ellwood-Yen, K. et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4, 223–238 (2003).
Amati, B., Alevizopoulos, K. & Vlach, J. Myc and the cell cycle. Frontiers Biosci. 3, d250–68 (1998).
Grandori, C., Cowley, S. M., James, L. P. & Eisenman, R. N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653–699 (2000).
Levens, D. L. Reconstructing MYC. Genes Dev. 17, 1071–1077 (2003).
Murphy, M. J., Wilson, A. & Trumpp, A. More than just proliferation: Myc function in stem cells. Trends Cell Biol. 15, 128–137 (2005).
Grandori, C. et al. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nature Cell Biol. 7, 311–318 (2005).
Arabi, A. et al. c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nature Cell Biol. 7, 303–310 (2005).
Trumpp, A. et al. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414, 768–773 (2001).
Adhikary, S. & Eilers, M. Transcriptional regulation and transformation by Myc proteins. Nature Rev. Mol. Cell Biol. 6, 635–645 (2005).
McMahon, S. B., Van Buskirk, H. A., Dugan, K. A., Copeland, T. D. & Cole, M. D. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94, 363–374 (1998).
Osborne, C. S. et al. Active genes dynamically colocalize to shared sites of ongoing transcription. Nature Genet. 36, 1065–1071 (2004).
Schuhmacher, M. et al. The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res. 29, 397–406 (2001).
Fernandez, P. C. et al. Genomic targets of the human c-Myc protein. Genes Dev. 17, 1115–1129 (2003).
Bergers, G., Graninger, P., Braselmann, S., Wrighton, C. & Busslinger, M. Transcriptional activation of the Fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol. Cell. Biol. 15, 3748–3758 (1995).
Adiseshaiah, P., Peddakama, S., Zhang, Q., Kalvakolanu, D. V. & Reddy, S. P. Mitogen regulated induction of FRA-1 proto-oncogene is controlled by the transcription factors binding to both serum and TPA response elements. Oncogene 24, 4193–4205 (2005).
Blackwell, T. K. et al. Binding of myc proteins to canonical and noncanonical DNA sequences. Mol. Cell. Biol. 13, 5216–5224 (1993).
Lasorella, A., Noseda, M., Beyna, M., Yokota, Y. & Iavarone, A. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 407, 592–598 (2000).
Zeller, K. I. et al. Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc. Natl Acad. Sci. USA 103, 17834–17839 (2006).
Schuhmacher, M. et al. Control of cell growth by c-Myc in the absence of cell division. Curr. Biol. 9, 1255–1258 (1999).
Pajic, A. et al. Cell cycle activation by c-myc in a Burkitt lymphoma model cell line. Int. J. Cancer 87, 787–793 (2000).
Eilers, M., Picard, D., Yamamoto, K. R. & Bishop, J. M. Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340, 66–68 (1989).
Kanno, T. et al. Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. Mol. Cell 13, 33–43 (2004).
Barratt, M. J., Hazzalin, C. A., Cano, E. & Mahadevan, L. C. Mitogen-stimulated phosphorylation of histone H3 is targeted to a small hyperacetylation-sensitive fraction. Proc. Natl Acad. Sci. USA 91, 4781–4785 (1994).
Cheung, P. et al. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol. Cell 5, 905–915 (2000).
Clayton, A. L., Rose, S., Barratt, M. J. & Mahadevan, L. C. Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. EMBO J. 19, 3714–3726 (2000).
Guccione, E. et al. Myc-binding-site recognition in the human genome is determined by chromatin context. Nature Cell Biol. 8, 764–770 (2006).
Nowak, S. J. & Corces, V. G. Phosphorylation of histone H3 correlates with transcriptionally active loci. Genes Dev. 14, 3003–3013 (2000).
Lefebvre, B., Ozato, K. & Lefebvre, P. Phosphorylation of histone H3 is functionally linked to retinoic acid receptor beta promoter activation. EMBO Rep. 3, 335–340 (2002).
Cole, M. D. & McMahon, S. B. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18, 2916–2924 (1999).
Caretti, G., Motta, M. C. & Mantovani, R. NF-Y associates with H3-H4 tetramers and octamers by multiple mechanisms. Mol. Cell. Biol. 19, 8591–8603 (1999).
Salameh, A., Galvagni, F., Bardelli, M., Bussolino, F. & Oliviero, S. Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways. Blood 106, 3423–3431 (2005).
Balsalobre, A., Damiola, F. & Schibler, U. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 93, 929–937 (1998).
Zhang, S., Herrmann, C. & Grosse, F. Nucleolar localization of murine nuclear DNA helicase II (RNA helicase A). J. Cell Sci. 112, 2693–2703 (1999).
Cirillo, L. A. & Zaret, K. S. Preparation of defined mononucleosomes, dinucleosomes, and nucleosome arrays in vitro and analysis of transcription factor binding. Methods Enzymol. 375, 131–158 (2004).
Kouskouti, A. & Talianidis, I. Histone modifications defining active genes persist after transcriptional and mitotic inactivation. EMBO J. 24, 347–357 (2005).
Acknowledgements
We thank all members of the laboratory for reagents, helpful suggestions and encouragement; M. Rocchigiani for VEGF-A preparations, B. Grandi for technical support, M. Bianchi for the YFP–H3 construct, R. Mantovani for Xenopus laevis histone constructs, B. Amati for Rat-1 and P493-6 cells, and I. Delany, M. Bianchi and E. Guccione for critical reading of the manuscript. This work was supported by Associazione Italiana Ricerca sul cancro (AIRC), Ministero Italiano Università e Ricerca (MIUR), and Fondazione Monte dei Paschi di Siena.
Author information
Authors and Affiliations
Contributions
A.Z. planned and performed the experiments and analysed the data. A.D.R. generated stable clones and performed immunoprecipitation experiments. R.S. performed the transformation assays. S.O. planned the experimental design, analysed the data and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Supplementary Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, Table S1, S2 and S3 (PDF 1013 kb)
Rights and permissions
About this article
Cite this article
Zippo, A., De Robertis, A., Serafini, R. et al. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation. Nat Cell Biol 9, 932–944 (2007). https://doi.org/10.1038/ncb1618
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb1618
This article is cited by
-
Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy
Clinical Epigenetics (2020)
-
PIM1 accelerates prostate cancer cell motility by phosphorylating actin capping proteins
Cell Communication and Signaling (2020)
-
Pim1 kinase positively regulates myoblast behaviors and skeletal muscle regeneration
Cell Death & Disease (2019)
-
Transmembrane protein GRINA modulates aerobic glycolysis and promotes tumor progression in gastric cancer
Journal of Experimental & Clinical Cancer Research (2018)
-
RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia
Leukemia (2018)